Immune-mediated syndromes following intravenous bisphosphonate therapy (Q38752243)

6 September 2017

Immune-mediated syndromes following intravenous bisphosphonate therapy (English)

1 reference

6 September 2017

Noa Markovits

1

1 reference

PubMed ID

28567535

6 September 2017

Ronen Loebstein

series ordinal

2

1 reference

PubMed ID

28567535

6 September 2017

Ilan Bank

series ordinal

3

1 reference

6 September 2017

31 May 2017

1 reference

6 September 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s10787-017-0365-9

6 September 2017

0 references

cites work

Clinical and immunological evaluation of zoledronate-activated Vgamma9gammadelta T-cell-based immunotherapy for patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Human gamma delta T cells: Evolution and ligand recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Identification of a putative second T-cell receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Acquired haemophilia A: a 2013 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Antigen-presenting effects of effector memory Vγ9Vδ2 T cells in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR gamma delta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

T gamma delta cells and their subsets in blood and synovial fluid from patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

A Novel Prothrombotic Pathway in Systemic Sclerosis Patients: Possible Role of Bisphosphonate-Activated γδ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Zoledronate stimulates gamma delta T cells in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Characterization of and risk factors for the acute-phase response after zoledronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Bisphosphonates target B cells to enhance humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Structural studies of Vgamma2Vdelta2 T cell phosphoantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10787-017-0365-9

Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells

21 January 2018

1 reference

12 December 2020

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma

1 reference

12 December 2020

GammadeltaT cells in juvenile idiopathic arthritis: higher percentages of synovial Vdelta1+ and Vgamma9+ T cell subsets are associated with milder disease

1 reference

12 December 2020

Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis

1 reference

12 December 2020

gamma delta-Lymphocytes in the peripheral blood of patients with rheumatoid arthritis--correlation with clinical and laboratory parameters of the disease and with the treatment used

1 reference

12 December 2020

Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells.

1 reference

12 December 2020

10.1007/S10787-017-0365-9

Identifiers

DOI

1 reference

6 September 2017

1 reference

PubMed ID

28567535